Literature DB >> 32187014

Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review.

Han Cui1, XiuWei Zhang2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a metabolic stress-induced liver injury closely correlated with insulin resistance. Currently, the methods for clinical management of NAFLD patients mainly include removing causes, changing lifestyle and dietary structure, drug therapy and weight-loss surgery. This paper summarizes the occurrence and clinical management of NAFLD in patients with obesity, with the aim of formulating scientific clinical interventions for these patients and thus preventing the occurrence of NAFLD.

Entities:  

Keywords:  NAFLD; clinical management; insulin resistance; obesity

Mesh:

Year:  2020        PMID: 32187014     DOI: 10.1515/jpem-2019-0595

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  2 in total

Review 1.  A Candidate Drug for Nonalcoholic Fatty Liver Disease: A Review of Pharmacological Activities of Polygoni Multiflori Radix.

Authors:  Mengting Zhou; Naihua Hu; Meichen Liu; Ying Deng; Linfeng He; Chaocheng Guo; Xingtao Zhao; Yunxia Li
Journal:  Biomed Res Int       Date:  2020-04-20       Impact factor: 3.411

2.  The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes.

Authors:  Minxuan Xu; Jun Tan; Wei Dong; Benkui Zou; Xuepeng Teng; Liancai Zhu; Chenxu Ge; Xianling Dai; Qin Kuang; Shaoyu Zhong; Lili Lai; Chao Yi; Tingting Tang; Junjie Zhao; Longyan Wang; Jin Liu; Hao Wei; Yan Sun; Qiufeng Yang; Qiang Li; Deshuai Lou; Linfeng Hu; Xi Liu; Gang Kuang; Jing Luo; Mingxin Xiong; Jing Feng; Chufeng Zhang; Bochu Wang
Journal:  Nat Commun       Date:  2022-02-25       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.